BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 15115119)

  • 1. Malaria, leprosy and dapsone.
    Saha K; Kapoor L; Arora VM; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):501-4. PubMed ID: 15115119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current malaria situation in Turkey].
    Gockchinar T; Kalipsi S
    Med Parazitol (Mosk); 2001; (1):44-5. PubMed ID: 11548315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia.
    Taylor WR; Richie TL; Fryauff DJ; Picarima H; Ohrt C; Tang D; Braitman D; Murphy GS; Widjaja H; Tjitra E; Ganjar A; Jones TR; Basri H; Berman J
    Clin Infect Dis; 1999 Jan; 28(1):74-81. PubMed ID: 10028075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How benign is benign tertian malaria?
    Sharma A; Khanduri U
    J Vector Borne Dis; 2009 Jun; 46(2):141-4. PubMed ID: 19502694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of MDT strategies through epidemiometric modeling.
    Lechat MF; Declercq EE; Misson CB; Vellut CM
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):296-301. PubMed ID: 2115904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The malaria situation in Afghanistan].
    Mustafa KS
    Med Parazitol (Mosk); 2000; (2):17-9. PubMed ID: 10900911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
    Biswas S; Mondal KK
    Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ahaptoglobinemia (HpO) and malaria in India.
    Joshi H; Subbarao SK; Valecha N; Sharma VP
    Indian J Malariol; 2002; 39(1-2):1-12. PubMed ID: 14686104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does dapsone resistance really matter in the MDT era?
    Ji B
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of imported malaria at the academic medical center, Amsterdam, the Netherlands.
    Baas MC; Wetsteyn JC; van Gool T
    J Travel Med; 2006; 13(1):2-7. PubMed ID: 16412103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary dapsone resistant Mycobacterium leprae in a non endemic country.
    Jamil A; Noor NM; Osman AS; Baseri MM; Muthupalaniappen L
    Indian J Dermatol Venereol Leprol; 2013; 79(4):527-9. PubMed ID: 23760326
    [No Abstract]   [Full Text] [Related]  

  • 13. Spatio-temporal distribution of Plasmodium falciparum and p. Vivax malaria in Thailand.
    Zhou G; Sirichaisinthop J; Sattabongkot J; Jones J; Bjørnstad ON; Yan G; Cui L
    Am J Trop Med Hyg; 2005 Mar; 72(3):256-62. PubMed ID: 15772317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of "cure by dapsone monotherapy' to the reduction of prevalence of leprosy in the State of Orissa, India, 1983-1993.
    Patnaik PK; McDougall AC
    Indian J Lepr; 1996; 68(3):223-6. PubMed ID: 8889607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria in pregnancy in the Solomon islands: barriers to prevention and control.
    Appleyard B; Tuni M; Cheng Q; Chen N; Bryan J; McCarthy JS
    Am J Trop Med Hyg; 2008 Mar; 78(3):449-54. PubMed ID: 18337342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia in malaria--correlation with type and severity of malaria.
    Jadhav UM; Patkar VS; Kadam NN
    J Assoc Physicians India; 2004 Aug; 52():615-8. PubMed ID: 15847353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.